Oberland Biotech Secures CHF 2.5 Million Seed Funding for Global Expansion
Oberland Biotech GmbH has raised CHF 2.5 million in seed funding through a convertible instrument, supported by 999 Family Office Pte. Ltd. The funding will be used to accelerate product development, international expansion, and marketing efforts, with a focus on the U.S. and Asian markets. The company operates in biotechnology and food innovation, exporting nutritional supplements and food products globally.
Topics: biotechnology funding international expansion nutritional supplements